JPRN-jRCT2080225358招募中3 期
An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease [M15-737]
AbbVie G.K0 个研究点目标入组 15 人开始时间: 2020年8月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a Intervention Model: Single Group Assignment Masking: None (open Label) Primary Purpose: Treatment
入排标准
- 年龄范围
- >= 30age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants who have Parkinson's Disease and who have successfully completed the parent study M15-741.
- •- Participants willing and able to comply with procedures required in the protocol.
排除标准
- •- Participants, if judged by the investigator to be unsuitable candidates to continue to receive ABBV-951 for any reason.
研究者
相似试验
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-SEAbbvie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-DEAbbvie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.Parkinson's DiseaseEUCTR2019-004235-23-GBAbbvie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-DKAbbvie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-NLAbbvie Deutschland GmbH & Co. KG130